Stárka L. Lékařské repetitorium endokrinologie. Praha: Triton 2010: 88-95.
Diaz-Thomas A, Pascual-y-Baralt JF. Pseudohypoaldosteronism. Emedicine. http://emedicine.medscape.com/article/924100.
Generalized pseudohypoaldosteronism type 1 (ORPHA171876), Renal pseudohypoaldosteronism type 1 (ORPHA171871), Pseudohypoaldosteronism type 2 (ORPHA757), www.orpha.net.
Zapletalová J, Geier P, Mihál V. Hyponatrémie jako příčina neprospívání. Čes.-slov. Pediat. 2005; 60(6): 385-388.
Dolezel Z, Starha J, Novotna D, Dostalkova D. Secondary pseudohypoaldosteronism in an infant with pyelonephritis. Bratisl. Lek. Listy 2004; 105(12): 435-437.Go to PubMed...
Štarha J, Doležel Z, Dostálková D. Jaká je Vaše diagnóza? Čes.-slov. Pediat. 2004; 59(10): 526.
Bogdanovic R, Stajic N, Putnik J, Paripovic A. Transient type 1 pseudohypoaldosteronism report on an eight-patient series and literature review. Pediatric Nephrology 2009; 24(11): 2167-2175.Go to original source...Go to PubMed...
Madam, Sir, please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert). Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.
I declare:
that I have met the above instruction
I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited